RedHill Biopharma Ltd. (RDHL)
NASDAQ: RDHL · Real-Time Price · USD
8.34
-0.51 (-5.76%)
Oct 22, 2024, 4:00 PM EDT - Market closed
RedHill Biopharma Market Cap
RedHill Biopharma has a market cap or net worth of $10.68 million as of October 23, 2024. Its market cap has increased by 870.88% in one year.
Market Cap
10.68M
Enterprise Value
3.96M
1-Year Change
870.88%
Ranking
Category
Stock Price
$8.34
Market Cap Chart
Since January 7, 2013, RedHill Biopharma's market cap has decreased from $58.80M to $10.68M, a decrease of -81.84%. That is a compound annual growth rate of -13.46%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 22, 2024 | 10.60M | 125.53% |
Dec 29, 2023 | 4.70M | -47.78% |
Dec 30, 2022 | 9.00M | -92.54% |
Dec 31, 2021 | 120.70M | -57.65% |
Dec 31, 2020 | 285.00M | 65.51% |
Dec 31, 2019 | 172.20M | 45.81% |
Dec 31, 2018 | 118.10M | 34.66% |
Dec 29, 2017 | 87.70M | -34.06% |
Dec 30, 2016 | 133.00M | 17.49% |
Dec 31, 2015 | 113.20M | 31.93% |
Dec 31, 2014 | 85.80M | 37.28% |
Dec 31, 2013 | 62.50M | 6.29% |
Jan 7, 2013 | 58.80M | - |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Brainstorm Cell Therapeutics | 11.27M |
PAVmed | 11.24M |
BioRestorative Therapies | 11.18M |
Conduit Pharmaceuticals | 10.87M |
Jaguar Health | 10.81M |
GlycoMimetics | 10.64M |
Alterity Therapeutics | 10.63M |
TransCode Therapeutics | 10.53M |